CLINICAL_TRIALS ClinicalTrials.gov record update

Treatment of Patients With Solid Tumor Cancers Via Intermediate-Size Patient Population Expanded Access Investigational New Drug (IND)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06980519
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:46.415536+00:00
Published At: 2025-05-22T00:00:00+00:00
Record Updated At: 2025-05-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Cancer", "Solid Tumor", "Solid Tumor Cancer", "Oncology", "uPAR-positive Solid Tumor", "Urokinase Plasminogen Activator Receptor-positive Solid Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-05-22"
protocolSection.identificationModule.nctId: "NCT06980519"
protocolSection.identificationModule.officialTitle: "Treatment of Patients With Solid Tumor Cancers Via Intermediate-Size Patient Population Expanded Access Investigational New Drug (IND)"
protocolSection.statusModule.overallStatus: "AVAILABLE"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.